Related Experiment Video
Updated: Nov 20, 2025

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
New Drugs for Rare Disorders.
1Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch : daschenbrenner@ndm.edu .
New medications offer hope for rare genetic disorders. Setmelanotide targets obesity, lumasiran addresses kidney disease, and lonafarnib treats premature aging conditions.
Area of Science:
- Medical Genetics
- Pharmacology
- Rare Diseases
Background:
- Rare genetic disorders present significant unmet medical needs.
- Limited therapeutic options exist for many of these conditions.
- Advancements in genetic understanding are driving targeted therapies.
Purpose of the Study:
- To highlight recent drug approvals for rare genetic conditions.
- To provide an overview of novel therapeutic agents and their indications.
Main Methods:
- Review of recent regulatory approvals for orphan drugs.
- Summary of drug mechanisms and target patient populations.
Main Results:
- Setmelanotide approved for genetic obesity conditions.
- Lumasiran indicated for primary hyperoxaluria type 1 (a kidney disorder).
- Lonafarnib approved for rare premature aging diseases.
Conclusions:
- Recent drug approvals signify progress in treating rare genetic disorders.
- These new therapies offer targeted treatment options for previously underserved patient groups.
- Continued research and development are crucial for rare disease therapeutics.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Therapy
Antianxiety Medications
FDA Approved Drugs: Changes to Approved Drugs
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Drug Regulation

